![](https://endpts.com/wp-content/uploads/2020/10/News_briefing_FE.jpg)
Inventiva restarts PhIII screening for MASH trial; CDMO announces small public offering
Plus, news about Zymeworks:
Inventiva resumes screening in PhIII MASH trial: The biotech lifted a voluntary pause it had placed on …
Sign up to read this article for free.
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.